Product Information
APREPITANT 80 MG CAPSULE is a generic product labeled by BluePoint Laboratories, priced at $76.3524 per EA under NDC 68001066701. Its NADAC has been published 35 times since Feb 4, 2026.
FDA first approved this application on Oct 12, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
80 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001066701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
APREPITANTApproval Type
Generic (ANDA)
FDA Application
ANDA207777FDA Approved
10/12/2017
TE Code
AB
On Market Since
12/1/2025
Pharmacological Classes
Price Statistics
The NADAC for APREPITANT 80 MG CAPSULE has been published 35 times since Feb 4, 2026, and over the history we have for it it has risen 6.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $76.3524 per EA |
|---|---|
| All-time high | $76.8519 (Sep 16, 2026) |
| All-time low | $63.4544 (May 20, 2026) |
| 52-week high | $76.8519 |
| 52-week low | $63.4544 |
| Median price | $69.0312 |
| Average price | $68.7868 |
| Largest weekly change | +8.8% (Jun 17, 2026) |
| Weeks tracked | 35 |
| Tracking since | Feb 4, 2026 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Aprepitant market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Substance P/Neurokinin-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of APREPITANT 80 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for APREPITANT 80 MG CAPSULE, manufactured by BluePoint Laboratories, is $76.3524 per EA (NDC 68001066701), effective Sep 30, 2026.
How has the price of APREPITANT 80 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for APREPITANT 80 MG CAPSULE has risen 6.2%. It has been tracked across 35 weekly CMS publications since Feb 4, 2026.
What are the highest and lowest recorded NADAC prices for APREPITANT 80 MG CAPSULE?
Since Feb 4, 2026, the NADAC for APREPITANT 80 MG CAPSULE has ranged from a low of $63.4544 (May 20, 2026) to a high of $76.8519 (Sep 16, 2026), with a median of $69.0312 per EA.
Are there cheaper alternatives to APREPITANT 80 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as APREPITANT 80 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures APREPITANT 80 MG CAPSULE?
APREPITANT 80 MG CAPSULE (NDC 68001066701) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.